The MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, Shanghai 200237, China.
J Agric Food Chem. 2023 Mar 1;71(8):3852-3861. doi: 10.1021/acs.jafc.2c09115. Epub 2023 Feb 15.
Ginsenosides are the main bioactive ingredients in plants of the genus . -ginsenoside R7 (VG-R7) is one of the rare high-value ginsenosides with health benefits. The only reported method for preparing VG-R7 involves inefficient and low-yield isolation from highly valuable natural resources. Notoginsenoside Fc (NG-Fc) isolated in the leaves and stems of is a suitable substrate for the preparation of VG-R7 via specific hydrolysis of the outside xylose at the C-20 position. Here, we first screened putative enzymes belonging to the glycoside hydrolase (GH) families 1, 3, and 43 and found that GH01 can specifically hydrolyze the β-d-xylopyranosyl-(1 → 6)-β-d-glucopyranoside linkage of NG-Fc to form VG-R7. The I248F/Y410R variant of GH01 obtained by protein engineering displayed a / value (305.3 min mM) for the reaction enhanced by approximately 270-fold compared with wild-type GH01. A change in the shape of the substrate binding pockets in the mutant allows the substrate to sit closer to the catalytic residues which may explain the enhanced catalytic efficiency of the engineered enzyme. This study identifies the first glycosidase for bioconversion of a ginsenoside with more than four sugar units, and it will inspire efforts to investigate other promising enzymes to obtain valuable natural products.
人参皂苷是属植物中的主要生物活性成分。-人参皂苷 R7(VG-R7)是一种具有健康益处的稀有高价值人参皂苷之一。目前报道的制备 VG-R7 的方法涉及从高价值天然资源中进行低效和低产的分离。从 叶子和茎中分离得到的拟人参皂苷 Fc(NG-Fc)是通过 C-20 位的特定水解作用制备 VG-R7 的合适底物,可在外糖基 20 位上水解β-d-吡喃木糖基-(1 → 6)-β-d-吡喃葡萄糖苷键。在这里,我们首先筛选了属于糖苷水解酶(GH)家族 1、3 和 43 的假定酶,发现 GH01 可以特异性地水解 NG-Fc 的β-d-吡喃木糖基-(1 → 6)-β-d-吡喃葡萄糖苷键,形成 VG-R7。通过蛋白质工程获得的 GH01 的 I248F/Y410R 变体与野生型 GH01 相比,反应的 / 值(305.3 min mM)提高了约 270 倍。突变体中底物结合口袋形状的改变使底物更接近催化残基,这可能解释了工程酶催化效率的提高。本研究鉴定了第一个用于具有四个以上糖单位的人参皂苷生物转化的糖苷酶,它将激发人们努力研究其他有前途的酶以获得有价值的天然产物。